Experts discuss cardiovascular disease modification in persons with HIV, including findings from the landmark REPRIEVE study

Experts discuss cardiovascular disease modification in persons with HIV, including findings from the landmark REPRIEVE study - Key expert updates from the 2023 IAS(HIV) Conference in Brisbane, Australia.

Leave a comment

Your email address will not be published. Required fields are marked *